GSA Capital Partners »

Acelrx Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $24k 21k 1.14

More positions owned by GSA Capital Partners

Ishares Tr Fltg Rate Nt Etf (FLOT)
NVIDIA Corporation (NVDA)
Remitly Global (RELY)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Cheniere Energy Com New (LNG)
Mobileye Global Common Class A (MBLY)
EOG Resources (EOG)
Pfizer (PFE)
Match Group (MTCH)
Frontline (FRO)
Tutor Perini Corporation (TPC)
Delek Us Holdings (DK)
Allstate Corporation (ALL)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)

View all positions for GSA Capital Partners

Top funds holding Acelrx Pharmaceuticals

AIGH Capital Management
Rock Springs Capital Management
Rosalind Advisors
Nantahala Capital Management
Empery Asset Management
Bleichroeder
Caption Management
Vanguard Group
Cantor Fitzgerald, L. P.
Geode Capital Management
Susquehanna International
Jane Street
Renaissance Technologies
Dauntless Investment Group
BlackRock

View all funds holding Acelrx Pharmaceuticals